Linagliptin Metformin Duo Tablet 2.5/1000 mg
Linagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
MFDS item code 202003651 · Approved 2020.05.19
This product's status changed to Expired on 2025.05.19. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of blood glucose control in adult type 2 diabetes
This medication is used in conjunction with dietary and exercise therapy to help control blood sugar levels in adults with type 2 diabetes. It is particularly administered in cases where patients have not previously received diabetes medication or have difficulty controlling blood sugar with monotherapy. It can also be used when metformin monotherapy is not effective. This medication can be used as an alternative to combination therapy of linagliptin and metformin, and both medications can be administered together when control of blood sugar is insufficient despite combined treatment with metformin and sulfonylureas. When effects are insufficient even with combination therapy of insulin and metformin, this medication can be taken together with insulin. Finally, when blood sugar is not controlled with combination therapy of metformin and empagliflozin, it is used in conjunction with empagliflozin. This medication is useful for improving blood glucose control in conjunction with various treatment methods.
This medication is administered twice daily with meals. 1. If not previously treated with metformin: Start with an initial dose of 2.5/500 mg, one tablet twice a day, with an increase to 2.5/1000 mg, one tablet twice a day if necessary. 2. When blood glucose control is difficult with metformin monotherapy: Start with an initial dose of linagliptin 2.5 mg twice daily along with the existing metformin dosing. 3.
This medication may cause a serious side effect known as lactic acidosis, thus it should not be used in certain patients. For example, it should not be administered to patients who are allergic to the components of this medication, have type 1 diabetes, severe renal impairment, acute infections, liver dysfunction, acute alcohol intoxication, or are pregnant women. Due to the risk of hypoglycemia, caution is needed when combining this medication with medications that can induce hypoglycemia, such as sulfonylureas or insulin, and dosage adjustments may be required. Since this medication is excreted through the kidneys, regular monitoring of kidney function is necessary, and it is safer not to use this medication in patients with impaired kidney function. Patients with weak cardiac function should carefully monitor both cardiac and renal function while using this medication. The intake of the medication should be temporarily suspended before and after the administration of iodine contrast agents used in radiological examinations, and it should be resumed only after kidney function has stabilized. It is also safe to discontinue the intake of this medication for a certain period before and after surgery. Rare side effects such as acute pancreatitis or bullous pemphigoid may occur during the use of this medication; therefore, if abdominal pain or skin rashes develop, patients should immediately inform their doctor. Vitamin B12 levels may decrease, so it is advisable to regularly check vitamin B12 status during long-term use. It is recommended that pregnant or breastfeeding women do not use this medication, and if pregnancy is planned, consultation with a doctor is necessary. It is not recommended for children under 10 years of age or adolescents aged 10 to 17 years since safety and efficacy have not been established. Elderly patients may have decreased kidney function, so it is essential to start with the minimum dosage and monitor kidney function frequently. This medication may interact with other drugs; therefore, patients should inform their doctor or pharmacist of any medications they are currently taking. In case of overdose, lactic acidosis may occur, so immediate medical attention is required if symptoms appear. Store out of reach of children and keep away from moisture.
Hives, angioedema, lactic acidosis, pancreatitis, bullous pemphigoid, liver dysfunction (abnormal liver function tests, hepatitis, jaundice), severe allergic reactions, severe skin adverse reactions, respiratory distress, asthma attacks, acute kidney injury, acute myocardial infarction, angina, unstable angina, cardiac arrest, stroke, seizures, confusion, visual disturbances, paralysis, severe myasthenia gravis, depression, acute cholangitis, acute cholecystitis, cholangitis.
Nasopharyngitis, various immune system disorders, vitamin B12 deficiency, hypoglycemia, taste disorder, cough, decreased appetite, diarrhea, constipation, nausea, vomiting, abdominal pain, oral ulcer formation, abnormal liver function tests, hepatitis, itching, erythema, rash, severe pain and disability-associated arthralgia, rhabdomyolysis, increased lipase, increased amylase, increased blood triglycerides, increased blood creatinine, pruritus, insomnia, depression, dizziness
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly closed container. The storage temperature should be kept between 1 and 30 degrees Celsius at room temperature to maintain the medication's efficacy for an extended period.
Bright pink oval film-coated tablet
60 tablets/box[(10 tablets/PTPX6)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Linagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
Linagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Anguk Pharm Co., Ltd.
Linagliptin 2.5mg · Metformin Hydrochloride 1000mg
Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Kukje Pharmaceutical Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.